Roman Butler Fullerton & Co. Has $226,000 Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Roman Butler Fullerton & Co. decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,057 shares of the company’s stock after selling 144 shares during the quarter. Roman Butler Fullerton & Co.’s holdings in GE HealthCare Technologies were worth $226,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of GEHC. First Command Advisory Services Inc. raised its stake in shares of GE HealthCare Technologies by 36,900.0% in the 3rd quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after purchasing an additional 369 shares during the period. Pin Oak Investment Advisors Inc. acquired a new stake in shares of GE HealthCare Technologies in the second quarter valued at about $25,000. Householder Group Estate & Retirement Specialist LLC acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at about $26,000. Legacy Financial Group LLC acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at about $26,000. Finally, OFI Invest Asset Management acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at about $26,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on GEHC shares. Evercore ISI lifted their target price on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Citigroup lifted their target price on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Morgan Stanley lifted their target price on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research report on Monday, February 12th. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and boosted their price target for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Finally, Mizuho boosted their price objective on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, April 11th. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average price target of $95.08.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $84.97 on Friday. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. The stock has a market capitalization of $38.77 billion, a P/E ratio of 28.14, a price-to-earnings-growth ratio of 2.96 and a beta of 0.94. The firm’s fifty day simple moving average is $88.67 and its two-hundred day simple moving average is $77.70. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.11. The business had revenue of $5.20 billion for the quarter, compared to analysts’ expectations of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The business’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.31 earnings per share. As a group, analysts predict that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a dividend of $0.03 per share. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.97%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.